These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15828816)

  • 21. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
    de Jong M; Breeman WA; Bakker WH; Kooij PP; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt MA; Erion JL; Bugaj JE; Mäcke HR; Krenning EP
    Cancer Res; 1998 Feb; 58(3):437-41. PubMed ID: 9458086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation.
    Yim CB; Dijkgraaf I; Merkx R; Versluis C; Eek A; Mulder GE; Rijkers DT; Boerman OC; Liskamp RM
    J Med Chem; 2010 May; 53(10):3944-53. PubMed ID: 20411957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
    Ginj M; Zhang H; Waser B; Cescato R; Wild D; Wang X; Erchegyi J; Rivier J; Mäcke HR; Reubi JC
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16436-41. PubMed ID: 17056720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
    Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
    J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors.
    Di Cianni A; Carotenuto A; Brancaccio D; Novellino E; Reubi JC; Beetschen K; Papini AM; Ginanneschi M
    J Med Chem; 2010 Aug; 53(16):6188-97. PubMed ID: 20666484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold nanoparticles conjugated to [Tyr3]octreotide peptide.
    Surujpaul PP; Gutiérrez-Wing C; Ocampo-García B; Ramírez Fde M; Arteaga de Murphy C; Pedraza-López M; Camacho-López MA; Ferro-Flores G
    Biophys Chem; 2008 Dec; 138(3):83-90. PubMed ID: 18819743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration.
    Melis M; Valkema R; Krenning EP; de Jong M
    J Nucl Med; 2012 May; 53(5):749-53. PubMed ID: 22496587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
    Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR studies reveal structural differences between the gallium and yttrium complexes of DOTA-D-Phe1-Tyr3-octreotide.
    Deshmukh MV; Voll G; Kühlewein A; Mäcke H; Schmitt J; Kessler H; Gemmecker G
    J Med Chem; 2005 Mar; 48(5):1506-14. PubMed ID: 15743193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radioiodinated MIBG-octreotate conjugate exhibiting enhanced uptake and retention in SSTR2-expressing tumor cells.
    Vaidyanathan G; Affleck DJ; Norman J; O'Dorisio S; Zalutsky MR
    Bioconjug Chem; 2007; 18(6):2122-30. PubMed ID: 17979223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.
    Stahl A; Meisetschläger G; Schottelius M; Bruus-Jensen K; Wolf I; Scheidhauer K; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):45-52. PubMed ID: 16151771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors.
    Miederer M; Henriksen G; Alke A; Mossbrugger I; Quintanilla-Martinez L; Senekowitsch-Schmidtke R; Essler M
    Clin Cancer Res; 2008 Jun; 14(11):3555-61. PubMed ID: 18519789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.
    Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ
    J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
    Valencak J; Heere-Ress E; Traub-Weidinger T; Raderer M; Schneeberger A; Thalhammer T; Aust S; Hamilton G; Virgolini I; Pehamberger H
    Melanoma Res; 2005 Dec; 15(6):523-9. PubMed ID: 16314738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
    Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
    J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.
    Ghosh SC; Rodriguez M; Carmon KS; Voss J; Wilganowski NL; Schonbrunn A; Azhdarinia A
    J Nucl Med; 2017 Nov; 58(11):1858-1864. PubMed ID: 28572490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
    Hofland LJ; Breeman WA; Krenning EP; de Jong M; Waaijers M; van Koetsveld PM; Mäcke HR; Lamberts SW
    Proc Assoc Am Physicians; 1999; 111(1):63-9. PubMed ID: 9893158
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.